Skip to main content

LP 164 LP 164 (Hydroxyurea 500 mg)

Pill with imprint LP 164 LP 164 is Green & Pink, Capsule-shape and has been identified as Hydroxyurea 500 mg. It is supplied by Leading Pharma, LLC.

Hydroxyurea is used in the treatment of chronic myelogenous leukemia; anemia, sickle cell; solid tumors and belongs to the drug class antimetabolites. There is positive evidence of human fetal risk during pregnancy. Hydroxyurea 500 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for LP 164 LP 164

Hydroxyurea 500 mg LP 164 LP 164

Hydroxyurea

Imprint
LP 164 LP 164
Strength
500 mg
Color
Green & Pink
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Antimetabolites
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Leading Pharma, LLC
National Drug Code (NDC)
69315-0164

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.